Is it possible for a Canadian interested in issues like scaling-up harm reduction and drug law reform to envy the U.S.? That’s the worrisome question that crossed my mind as I sat in the opening plenary of the 9th National Harm Reduction Conference in Portland, Oregon.
Two U.S. states recently voted to pass ballot initiatives that would end the prohibition of cannabis use by adults. And in the spirit of dignity, law reform and harm reduction activists have championed a myriad of community-based and public health department-led initiatives to scale-up overdose prevention and response programs. That reality is evident here in Portland, given the number of sessions devoted to this topic. Speakers like Willie Dudley of Casa Segura in Oakland, CA, talked about the empowerment experienced by peers who’ve been trained to respond to overdoses with the opiate agonist Naloxone.
And then there’s Gil Kerlikowske. He’s the head of the White House’s Office on National Drug Control Policy. Given the recent U.S. election outcome, it looks like he gets to keep his job as Obama’s drug Czar. Typically that office has championed the war on drugs and all its brutality, but Kerlikowske delivered welcoming remarks to the delegates in Portland via video feed. He took pains to note that he was the first person in his position to do so. Likely his appearance at this conference is the result of the hard work of relationship building done by people like Allan Clear, head of the New York-based Harm Reduction Coalition. Kerlikowske reiterated his support for syringe exchange and echoed the commitment made by his office this past summer to support the scale-up of overdose programs including making Naloxone more readily available.
Of course rhetoric is one thing and reality is another. Behind Kerlikowske’s words is still the reality of the U.S.-led war on drugs, which includes American support for the militarization of the drug war along the Mexico/U.S. border. There’s still a federal ban on funding for syringe distribution re-imposed by a Republican controlled congress in 2010. And there are still thousands of arrests daily for drug possession. One need only to turn briefly to Michelle Alexander’s book, The New Jim Crow, to be astutely reminded that this drug war is a racist one. But then again, these realities are also true in Canada where First Nations people are disproportionately imprisoned, where Canada also supports the militarization of the U.S./Mexico drug war and where harm reduction has been redlined in the National Anti-Drug Strategy.
Yes it’s true that we have deep political resistance to harm reduction in Canada but nevertheless we must figure how we can work together across the country to scale-up harm reduction services. We can’t keep it secret anymore. The proponents of harm reduction have created a profoundly important practice of health engagement and we have something to teach the rest of the system. So let’s get that conversation going. If you’ve already started, let us know what works best and we will share that wisdom with everyone who will listen.
